Publication | Open Access

Protracted oral etoposide in epithelial ovarian cancer: a phase II study in patients with relapsed or platinum-resistant disease

Epithelial Ovarian CancerMedicineOral EtoposideGynecologyPhase Ii StudyCancer TreatmentOncologyRadiation OncologyEndocrine-related CancerOral CancerOvarian Cancer